Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CME vs MRNA✓SelectedUSD · MRNACME vs MRNA performance historyLatest closeAs of+0.44%11/16
Stock and ETF performance explorer

CME vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+71.0%
MRNA return
+182.7%
Excess return
-111.7%
Maximum drawdown
-31.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.4%-3.6%+4.1%+0.4%
7D+4.9%-20.0%+24.9%+4.5%
30D+8.7%-1.3%+9.9%+8.7%
3M+18.9%+240.0%-221.0%+22.6%
6M+7.9%+339.0%-331.0%+12.1%
YTD+20.9%+630.0%-609.0%+26.8%
1Y+16.4%+769.1%-752.7%+22.4%
3Y+71.0%+181.2%-110.2%+85.9%
All+71.0%+182.7%-111.7%+85.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling